A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
1 other identifier
observational
250,000
1 country
1
Brief Summary
This study is to clarify the distribution characteristics, host and clinical characteristics, disease outcome and risk factors, changes of multiple organs such as cardiopulmonary function and changes in social and psychological indicators during long-term follow-up of omicron variant asymptomatic infections and diagnosed patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2022
CompletedFirst Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2032
May 24, 2022
May 1, 2022
10.2 years
May 23, 2022
May 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
long-term outcomes，changes of clinical characteristic and social psychology
the 3rd，6th，9th month，average one year discharge from hospital
10 years
Study Arms (1)
COVID-19 infections
SARS-Cov-2 RNA postive
Eligibility Criteria
asymptomatic infections and diagnosed patients with COVID-19 in fangcang shelter hospitals in Shanghai
You may qualify if:
- SARS-Cov-2-RNA positive
- informed consent signed
You may not qualify if:
- informed consent rejected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guang Ning, Ph D
Ruijin Hospital
- PRINCIPAL INVESTIGATOR
Erzhen Chen, Ph D
Ruijin Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
May 24, 2022
Study Start
March 29, 2022
Primary Completion (Estimated)
May 31, 2032
Study Completion (Estimated)
May 31, 2032
Last Updated
May 24, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
The data are not publicity available due to privacy and ethical restrictions